Literature DB >> 27030938

Selective Androgen Receptor Modulators as Function Promoting Therapies.

S Bhasin1.   

Abstract

Entities:  

Year:  2015        PMID： 27030938      PMCID： PMC6039107          DOI： 10.14283/jfa.2015.65

Source DB:  PubMed          Journal:  J Frailty Aging        ISSN： 2260-1341


× No keyword cloud information.
  13 in total

Review 1.  Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium.

Authors:  A Negro-Vilar
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

3.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

4.  The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

Authors:  S Bhasin; T W Storer; N Berman; C Callegari; B Clevenger; J Phillips; T J Bunnell; R Tricker; A Shirazi; R Casaburi
Journal:  N Engl J Med       Date:  1996-07-04       Impact factor: 91.245

5.  An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.

Authors:  Jeffrey N Miner; William Chang; Mark S Chapman; Patricia D Finn; Mei Hua Hong; Francisco J López; Keith B Marschke; Jon Rosen; William Schrader; Russell Turner; Arjan van Oeveren; Humberto Viveros; Lin Zhi; Andres Negro-Vilar
Journal:  Endocrinology       Date:  2006-10-05       Impact factor: 4.736

6.  The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.

Authors:  Shehzad Basaria; Lauren Collins; E Lichar Dillon; Katie Orwoll; Thomas W Storer; Renee Miciek; Jagadish Ulloor; Anqi Zhang; Richard Eder; Heather Zientek; Gilad Gordon; Syed Kazmi; Melinda Sheffield-Moore; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

7.  Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation.

Authors:  Thomas G Travison; Shehzad Basaria; Thomas W Storer; Alan M Jette; Renee Miciek; Wildon R Farwell; Karen Choong; Kishore Lakshman; Norman A Mazer; Andrea D Coviello; Philip E Knapp; Jagadish Ulloor; Anqi Zhang; Brad Brooks; Ahn-Hoa Nguyen; Richard Eder; Nathan LeBrasseur; Ayan Elmi; Erica Appleman; Leife Hede-Brierley; Geeta Bhasin; Ashmeet Bhatia; Antonio Lazzari; Samuel Davis; Pengsheng Ni; Lauren Collins; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-06-22       Impact factor: 6.053

Review 8.  Selective androgen receptor modulators as function promoting therapies.

Authors:  Shalender Bhasin; Ravi Jasuja
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-05       Impact factor: 4.294

9.  A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia.

Authors:  D A Papanicolaou; S N Ather; H Zhu; Y Zhou; J Lutkiewicz; B B Scott; J Chandler
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

Review 10.  Selective androgen receptor modulators in preclinical and clinical development.

Authors:  Ramesh Narayanan; Michael L Mohler; Casey E Bohl; Duane D Miller; James T Dalton
Journal:  Nucl Recept Signal       Date:  2008-11-26
View more
  3 in total

1.  Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women.

Authors:  Richard V Clark; Ann C Walker; Susan Andrews; Philip Turnbull; Jeffrey A Wald; Mindy H Magee
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

Review 2.  Selective androgen receptor modulators: the future of androgen therapy?

Authors:  Andrew R Christiansen; Larry I Lipshultz; James M Hotaling; Alexander W Pastuszak
Journal:  Transl Androl Urol       Date:  2020-03

3.  Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model.

Authors:  Paul Jonathan Roch; Danny Henkies; Jan Christoph Carstens; Carsten Krischek; Wolfgang Lehmann; Marina Komrakova; Stephan Sehmisch
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-17       Impact factor: 5.555
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.